A daily pill may be as effective in lowering blood sugar and aiding weight loss as injections like Ozempic.

Lilly's oral orforglipron demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 drugs in successful Phase 3 trial.